Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study

Allogeneic stem cell transplantation (allo-SCT) from HLA-identical donors (HLAid) could be an effective salvage treatment for relapsed/refractory lymphoma. In this setting, standard graft-versus-host disease (GVHD) prophylaxis is based on cyclosporine and methotrexate, with the addition of anti-thym...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefania Bramanti, Daniela Taurino, Filippo Magri, Chiara De Philippis, Barbara Sarina, Luca Castagna, Laura Giordano, Jacopo Mariotti, Daniele Mannina, Armando Santoro
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Life
Subjects:
allo-SCT
GVHD
prophylaxis
cyclophosphamide
lymphoma
Online Access:https://www.mdpi.com/2075-1729/15/3/393
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items